

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.70667170 |
| 2 | leukocyte aggregation (GO:0070486) | 6.34224019 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.09610471 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.09610471 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.98938024 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.98938024 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.92873997 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.80774709 |
| 9 | positive thymic T cell selection (GO:0045059) | 5.52699938 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.35586392 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.33674587 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 5.33674587 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.33674587 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.33674587 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.33674587 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 5.33674587 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.30728817 |
| 18 | response to interleukin-15 (GO:0070672) | 5.19687925 |
| 19 | negative thymic T cell selection (GO:0045060) | 5.19376496 |
| 20 | negative T cell selection (GO:0043383) | 5.13910525 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.95671737 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 4.84604936 |
| 23 | detection of other organism (GO:0098543) | 4.75757740 |
| 24 | thymic T cell selection (GO:0045061) | 4.71005647 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.69513125 |
| 26 | positive T cell selection (GO:0043368) | 4.61686883 |
| 27 | cellular extravasation (GO:0045123) | 4.61244399 |
| 28 | morphogenesis of an endothelium (GO:0003159) | 4.60649670 |
| 29 | endothelial tube morphogenesis (GO:0061154) | 4.60649670 |
| 30 | interferon-gamma production (GO:0032609) | 4.44182905 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 4.35291065 |
| 32 | regulation of B cell differentiation (GO:0045577) | 4.31166432 |
| 33 | T cell selection (GO:0045058) | 4.20434037 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 4.17809794 |
| 35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.02430788 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.98223831 |
| 37 | response to peptidoglycan (GO:0032494) | 3.91648185 |
| 38 | positive regulation of lamellipodium assembly (GO:0010592) | 3.90596827 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.88380300 |
| 40 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.83136420 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.80422672 |
| 42 | T cell migration (GO:0072678) | 3.79374477 |
| 43 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.77759355 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.75213505 |
| 45 | T cell receptor signaling pathway (GO:0050852) | 3.72187993 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.71965118 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.70992190 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.68254083 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.64529268 |
| 50 | response to host immune response (GO:0052572) | 3.64529268 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.63893707 |
| 52 | leukocyte cell-cell adhesion (GO:0007159) | 3.63717018 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.61321878 |
| 54 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.59366790 |
| 55 | T cell homeostasis (GO:0043029) | 3.58179506 |
| 56 | sequestering of actin monomers (GO:0042989) | 3.57639023 |
| 57 | T cell costimulation (GO:0031295) | 3.56863462 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.53012224 |
| 59 | lymphocyte costimulation (GO:0031294) | 3.52082931 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50877045 |
| 61 | microglial cell activation (GO:0001774) | 3.48160119 |
| 62 | positive regulation of lamellipodium organization (GO:1902745) | 3.46753162 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43585880 |
| 64 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.43103449 |
| 65 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.42220562 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40051765 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.39630600 |
| 68 | tolerance induction (GO:0002507) | 3.35725850 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33631288 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 3.33462778 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.33011481 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.33011481 |
| 73 | positive regulation of tolerance induction (GO:0002645) | 3.31384609 |
| 74 | granulocyte activation (GO:0036230) | 3.30986402 |
| 75 | activated T cell proliferation (GO:0050798) | 3.30224040 |
| 76 | response to host (GO:0075136) | 3.30202747 |
| 77 | response to host defenses (GO:0052200) | 3.30202747 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30202747 |
| 79 | detection of biotic stimulus (GO:0009595) | 3.28731493 |
| 80 | neutrophil mediated immunity (GO:0002446) | 3.26190875 |
| 81 | response to muramyl dipeptide (GO:0032495) | 3.26110629 |
| 82 | detection of molecule of bacterial origin (GO:0032490) | 3.25266395 |
| 83 | regulation of mast cell activation (GO:0033003) | 3.24775067 |
| 84 | macrophage activation (GO:0042116) | 3.23372731 |
| 85 | leukocyte degranulation (GO:0043299) | 3.21754832 |
| 86 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.21114502 |
| 87 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.19495759 |
| 88 | regulation of response to interferon-gamma (GO:0060330) | 3.18277990 |
| 89 | cellular response to zinc ion (GO:0071294) | 3.13090862 |
| 90 | B cell mediated immunity (GO:0019724) | 3.12607488 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 3.11554838 |
| 92 | germinal center formation (GO:0002467) | 3.09272951 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 3.08312858 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.08146432 |
| 95 | lymphocyte homeostasis (GO:0002260) | 3.06928172 |
| 96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03295544 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03295544 |
| 98 | megakaryocyte development (GO:0035855) | 3.02846943 |
| 99 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.01362151 |
| 100 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01016494 |
| 101 | mast cell activation (GO:0045576) | 2.97269310 |
| 102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96996788 |
| 103 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94624446 |
| 104 | respiratory burst (GO:0045730) | 2.93612791 |
| 105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93422014 |
| 106 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92996907 |
| 107 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.91892269 |
| 108 | positive regulation of isotype switching (GO:0045830) | 2.91778738 |
| 109 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89476146 |
| 110 | negative regulation of innate immune response (GO:0045824) | 2.89153604 |
| 111 | positive regulation of mast cell activation (GO:0033005) | 2.88424539 |
| 112 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87537910 |
| 113 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.85333352 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.84881544 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 2.84737604 |
| 116 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.84543505 |
| 117 | regulation of defense response to virus by virus (GO:0050690) | 2.83442118 |
| 118 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.80125576 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.79950589 |
| 120 | NIK/NF-kappaB signaling (GO:0038061) | 2.79092588 |
| 121 | regulation of granulocyte differentiation (GO:0030852) | 2.78847376 |
| 122 | regulation of tolerance induction (GO:0002643) | 2.76128146 |
| 123 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74410585 |
| 124 | leukocyte homeostasis (GO:0001776) | 2.74362397 |
| 125 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.73639986 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.73639986 |
| 127 | actin nucleation (GO:0045010) | 2.72557741 |
| 128 | barbed-end actin filament capping (GO:0051016) | 2.71654715 |
| 129 | mature B cell differentiation (GO:0002335) | 2.70757483 |
| 130 | response to protozoan (GO:0001562) | 2.70669332 |
| 131 | leukocyte tethering or rolling (GO:0050901) | 2.67363223 |
| 132 | negative regulation of interleukin-12 production (GO:0032695) | 2.66500159 |
| 133 | natural killer cell activation (GO:0030101) | 2.65790920 |
| 134 | detection of bacterium (GO:0016045) | 2.60543081 |
| 135 | defense response to protozoan (GO:0042832) | 2.60489494 |
| 136 | neutrophil activation (GO:0042119) | 2.60241429 |
| 137 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59611713 |
| 138 | positive regulation of DNA recombination (GO:0045911) | 2.58241035 |
| 139 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.57860318 |
| 140 | regulation of B cell mediated immunity (GO:0002712) | 2.57230582 |
| 141 | response to type I interferon (GO:0034340) | 2.57106793 |
| 142 | blood vessel maturation (GO:0001955) | 2.56869762 |
| 143 | macrophage differentiation (GO:0030225) | 2.56313469 |
| 144 | positive regulation of B cell activation (GO:0050871) | 2.55700038 |
| 145 | angiogenesis involved in wound healing (GO:0060055) | 2.55110155 |
| 146 | lymph node development (GO:0048535) | 2.54804343 |
| 147 | positive regulation of B cell mediated immunity (GO:0002714) | 2.53093635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.08423509 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.56614833 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.54761515 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.84883493 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.68123347 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.21354292 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.12072881 |
| 8 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.09297679 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.08263993 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.07025358 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05868850 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.03447168 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.93954091 |
| 14 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87769360 |
| 15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85174377 |
| 16 | * MYB_26560356_Chip-Seq_TH2_Human | 2.73379458 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.73083303 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68529906 |
| 19 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63054318 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60669043 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48172403 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.47863873 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.43448302 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39545941 |
| 25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38117637 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.35834613 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.33303136 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.32355876 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31148865 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18001006 |
| 31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.16747675 |
| 32 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16285881 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15411636 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13911244 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12835420 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.12252637 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11069491 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10100809 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.05014583 |
| 40 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04306246 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.98987717 |
| 42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98616829 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93970447 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92647554 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.90477198 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.88237337 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83655013 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82483012 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77469453 |
| 50 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70693866 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68073183 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66355514 |
| 53 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63894427 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59617388 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50544507 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47817248 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47583616 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46763267 |
| 59 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44298406 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39468015 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39173197 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38994965 |
| 63 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38878776 |
| 64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.33990156 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29612281 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29511507 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29460261 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29326468 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28105763 |
| 70 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23172057 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19840810 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17395345 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16821363 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16431777 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16357882 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16233955 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14805234 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13914989 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12758579 |
| 80 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09862644 |
| 81 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09661403 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08170001 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06605916 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04425684 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02605193 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02241905 |
| 87 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01229724 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00563216 |
| 89 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99975766 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99683446 |
| 91 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98067781 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96183927 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95076443 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94145378 |
| 95 | * P68_20966046_ChIP-Seq_HELA_Human | 0.93976510 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93856138 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92646365 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92466816 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92216702 |
| 100 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91751375 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90739102 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90373446 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89045875 |
| 104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87923826 |
| 105 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86677115 |
| 106 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86048976 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84999665 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83341814 |
| 109 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82095833 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81482111 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79616760 |
| 112 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79146211 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76414631 |
| 114 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76067798 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73804704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.70292856 |
| 2 | MP0005671_abnormal_response_to | 3.53737042 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.36906234 |
| 4 | MP0002396_abnormal_hematopoietic_system | 3.04260901 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.02141724 |
| 6 | MP0009785_altered_susceptibility_to | 2.91139568 |
| 7 | MP0003724_increased_susceptibility_to | 2.89283589 |
| 8 | MP0000685_abnormal_immune_system | 2.88877634 |
| 9 | MP0003303_peritoneal_inflammation | 2.82324363 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 2.72854561 |
| 11 | MP0001790_abnormal_immune_system | 2.72579509 |
| 12 | MP0005387_immune_system_phenotype | 2.72579509 |
| 13 | MP0009278_abnormal_bone_marrow | 2.71456578 |
| 14 | * MP0001819_abnormal_immune_cell | 2.70634590 |
| 15 | MP0002398_abnormal_bone_marrow | 2.65699576 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.55419564 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.53121422 |
| 18 | * MP0002723_abnormal_immune_serum | 2.52430630 |
| 19 | MP0003436_decreased_susceptibility_to | 2.49087801 |
| 20 | MP0005025_abnormal_response_to | 2.39005353 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.36435983 |
| 22 | * MP0000716_abnormal_immune_system | 2.26841551 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 2.19717101 |
| 24 | MP0002405_respiratory_system_inflammati | 2.18700752 |
| 25 | MP0002419_abnormal_innate_immunity | 2.16955044 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.10398171 |
| 27 | MP0002722_abnormal_immune_system | 2.08290294 |
| 28 | * MP0000689_abnormal_spleen_morphology | 2.07273504 |
| 29 | MP0000703_abnormal_thymus_morphology | 2.06415600 |
| 30 | MP0010368_abnormal_lymphatic_system | 2.04734895 |
| 31 | * MP0002429_abnormal_blood_cell | 1.94738806 |
| 32 | MP0004510_myositis | 1.92046689 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.89682777 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.89246485 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.85066979 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.85066979 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.81451386 |
| 38 | MP0006082_CNS_inflammation | 1.80119514 |
| 39 | MP0003828_pulmonary_edema | 1.75904924 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.71895114 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.69301130 |
| 42 | MP0001879_abnormal_lymphatic_vessel | 1.68696030 |
| 43 | MP0001873_stomach_inflammation | 1.67018686 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.66747786 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.66541401 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.58844496 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.58326376 |
| 48 | MP0008260_abnormal_autophagy | 1.53389069 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.48143820 |
| 50 | MP0003866_abnormal_defecation | 1.47635059 |
| 51 | MP0000858_altered_metastatic_potential | 1.38761473 |
| 52 | MP0001853_heart_inflammation | 1.38388529 |
| 53 | MP0004947_skin_inflammation | 1.38294227 |
| 54 | MP0000343_altered_response_to | 1.38147049 |
| 55 | MP0002933_joint_inflammation | 1.37795863 |
| 56 | MP0004381_abnormal_hair_follicle | 1.35850224 |
| 57 | MP0001851_eye_inflammation | 1.27007293 |
| 58 | MP0002006_tumorigenesis | 1.20434210 |
| 59 | MP0003448_altered_tumor_morphology | 1.16594304 |
| 60 | MP0003690_abnormal_glial_cell | 1.13198336 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.09590270 |
| 62 | MP0003279_aneurysm | 1.08573592 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.04621871 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.02637987 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.02078578 |
| 66 | MP0002132_abnormal_respiratory_system | 1.00869338 |
| 67 | MP0003693_abnormal_embryo_hatching | 1.00235588 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.99394868 |
| 69 | MP0008469_abnormal_protein_level | 0.98620997 |
| 70 | MP0000767_abnormal_smooth_muscle | 0.96625052 |
| 71 | MP0003075_altered_response_to | 0.95361067 |
| 72 | MP0005174_abnormal_tail_pigmentation | 0.95327911 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.94952780 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.92423004 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.91809804 |
| 76 | MP0003077_abnormal_cell_cycle | 0.89130377 |
| 77 | MP0001663_abnormal_digestive_system | 0.89071268 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 0.88926216 |
| 79 | MP0009764_decreased_sensitivity_to | 0.88541432 |
| 80 | MP0000490_abnormal_crypts_of | 0.88076652 |
| 81 | MP0004130_abnormal_muscle_cell | 0.85865709 |
| 82 | MP0000249_abnormal_blood_vessel | 0.85155256 |
| 83 | MP0004084_abnormal_cardiac_muscle | 0.84979430 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.83563922 |
| 85 | MP0008874_decreased_physiological_sensi | 0.81472425 |
| 86 | MP0005310_abnormal_salivary_gland | 0.81091846 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.80277739 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 0.80124817 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.79004445 |
| 90 | MP0010630_abnormal_cardiac_muscle | 0.76286943 |
| 91 | MP0005164_abnormal_response_to | 0.74558766 |
| 92 | MP0005451_abnormal_body_composition | 0.72837015 |
| 93 | MP0006054_spinal_hemorrhage | 0.72064920 |
| 94 | MP0003045_fibrosis | 0.71197210 |
| 95 | MP0005390_skeleton_phenotype | 0.69138691 |
| 96 | MP0008004_abnormal_stomach_pH | 0.66355720 |
| 97 | MP0002925_abnormal_cardiovascular_devel | 0.65850425 |
| 98 | MP0005535_abnormal_body_temperature | 0.65524991 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63586673 |
| 100 | MP0001544_abnormal_cardiovascular_syste | 0.63509101 |
| 101 | MP0005385_cardiovascular_system_phenoty | 0.63509101 |
| 102 | MP0002127_abnormal_cardiovascular_syste | 0.60467651 |
| 103 | MP0004883_abnormal_blood_vessel | 0.60098676 |
| 104 | MP0005166_decreased_susceptibility_to | 0.59111674 |
| 105 | MP0004147_increased_porphyrin_level | 0.58848117 |
| 106 | MP0004484_altered_response_of | 0.57010723 |
| 107 | MP0009763_increased_sensitivity_to | 0.56937787 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.56871882 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.56285570 |
| 110 | MP0002928_abnormal_bile_duct | 0.56097866 |
| 111 | MP0003787_abnormal_imprinting | 0.55567265 |
| 112 | MP0000313_abnormal_cell_death | 0.55301109 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.54870485 |
| 114 | MP0002095_abnormal_skin_pigmentation | 0.54595260 |
| 115 | MP0003111_abnormal_nucleus_morphology | 0.54385826 |
| 116 | MP0005023_abnormal_wound_healing | 0.53163225 |
| 117 | MP0008007_abnormal_cellular_replicative | 0.53064781 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.51461527 |
| 119 | MP0005388_respiratory_system_phenotype | 0.51229214 |
| 120 | MP0002133_abnormal_respiratory_system | 0.51229214 |
| 121 | MP0000604_amyloidosis | 0.50910591 |
| 122 | MP0002822_catalepsy | 0.50901150 |
| 123 | MP0002972_abnormal_cardiac_muscle | 0.49991049 |
| 124 | MP0003646_muscle_fatigue | 0.49915293 |
| 125 | MP0008995_early_reproductive_senescence | 0.49732121 |
| 126 | MP0000266_abnormal_heart_morphology | 0.49552843 |
| 127 | MP0005058_abnormal_lysosome_morphology | 0.47746281 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.47677651 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.46762779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 5.41397903 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.97130257 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.72399523 |
| 4 | Myositis (HP:0100614) | 4.65660922 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 4.54312224 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.53273816 |
| 7 | Chronic otitis media (HP:0000389) | 4.31330438 |
| 8 | T lymphocytopenia (HP:0005403) | 4.27602869 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.20600177 |
| 10 | Abnormality of T cell number (HP:0011839) | 4.10912498 |
| 11 | IgM deficiency (HP:0002850) | 4.03815748 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.02052607 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.00272279 |
| 14 | Meningitis (HP:0001287) | 3.95953996 |
| 15 | Agammaglobulinemia (HP:0004432) | 3.81499570 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.78367930 |
| 17 | Obstructive lung disease (HP:0006536) | 3.77329122 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.77329122 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.71440652 |
| 20 | Cellulitis (HP:0100658) | 3.70043840 |
| 21 | Abnormality of the fingertips (HP:0001211) | 3.62359583 |
| 22 | Nasal polyposis (HP:0100582) | 3.55427175 |
| 23 | Abnormality of T cells (HP:0002843) | 3.48853190 |
| 24 | Recurrent viral infections (HP:0004429) | 3.41302993 |
| 25 | Hypochromic microcytic anemia (HP:0004840) | 3.39694130 |
| 26 | Hematochezia (HP:0002573) | 3.39173713 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.33254040 |
| 28 | Stomatitis (HP:0010280) | 3.32501716 |
| 29 | Inflammation of the large intestine (HP:0002037) | 3.29241953 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.21413143 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.21413143 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.20888712 |
| 33 | Hemoptysis (HP:0002105) | 3.13341173 |
| 34 | Hypochromic anemia (HP:0001931) | 3.09102004 |
| 35 | Recurrent skin infections (HP:0001581) | 3.06181951 |
| 36 | Orchitis (HP:0100796) | 3.05101839 |
| 37 | Prolonged bleeding time (HP:0003010) | 3.04846195 |
| 38 | Lymphopenia (HP:0001888) | 3.00112933 |
| 39 | Vasculitis (HP:0002633) | 2.98395697 |
| 40 | Thyroiditis (HP:0100646) | 2.97588508 |
| 41 | Increased IgM level (HP:0003496) | 2.92800166 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89232292 |
| 43 | Pustule (HP:0200039) | 2.85744911 |
| 44 | Chest pain (HP:0100749) | 2.82510360 |
| 45 | IgG deficiency (HP:0004315) | 2.81398681 |
| 46 | Encephalitis (HP:0002383) | 2.81292913 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.80172526 |
| 48 | Episodic fever (HP:0001954) | 2.78065885 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.74827110 |
| 50 | Optic neuritis (HP:0100653) | 2.74827110 |
| 51 | Combined immunodeficiency (HP:0005387) | 2.73878331 |
| 52 | Leukocytosis (HP:0001974) | 2.71455831 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.67544468 |
| 54 | Papilloma (HP:0012740) | 2.66221013 |
| 55 | Verrucae (HP:0200043) | 2.66221013 |
| 56 | Gingival bleeding (HP:0000225) | 2.64672293 |
| 57 | Chronic sinusitis (HP:0011109) | 2.64606811 |
| 58 | Polycythemia (HP:0001901) | 2.63899525 |
| 59 | Colitis (HP:0002583) | 2.61074752 |
| 60 | Recurrent sinusitis (HP:0011108) | 2.60093533 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.59887151 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58714083 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.57346272 |
| 64 | Epistaxis (HP:0000421) | 2.55366055 |
| 65 | Microcytic anemia (HP:0001935) | 2.50249136 |
| 66 | Thrombocytosis (HP:0001894) | 2.45393707 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.45158243 |
| 68 | Bronchitis (HP:0012387) | 2.44524520 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.44419398 |
| 70 | Pulmonary embolism (HP:0002204) | 2.44308248 |
| 71 | Recurrent pneumonia (HP:0006532) | 2.38088358 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.37917593 |
| 73 | B lymphocytopenia (HP:0010976) | 2.37917593 |
| 74 | Abnormality of the peritoneum (HP:0002585) | 2.36444067 |
| 75 | Gingivitis (HP:0000230) | 2.33760205 |
| 76 | Peritonitis (HP:0002586) | 2.33014374 |
| 77 | Arterial thrombosis (HP:0004420) | 2.30913816 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.30166278 |
| 79 | Eosinophilia (HP:0001880) | 2.28020747 |
| 80 | Emphysema (HP:0002097) | 2.24854297 |
| 81 | Sepsis (HP:0100806) | 2.23524534 |
| 82 | Purpura (HP:0000979) | 2.22613860 |
| 83 | Papilledema (HP:0001085) | 2.21812083 |
| 84 | Anorexia (HP:0002039) | 2.21547072 |
| 85 | Lymphoma (HP:0002665) | 2.18839744 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.18373479 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.17459723 |
| 88 | Hemiplegia (HP:0002301) | 2.16988761 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16165151 |
| 90 | Abnormality of the endocardium (HP:0004306) | 2.16040997 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.11143056 |
| 92 | Vertigo (HP:0002321) | 2.07432518 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.07304059 |
| 94 | Restrictive lung disease (HP:0002091) | 2.06760000 |
| 95 | Chronic diarrhea (HP:0002028) | 2.06004246 |
| 96 | Amyloidosis (HP:0011034) | 2.01513512 |
| 97 | Gangrene (HP:0100758) | 2.00770676 |
| 98 | Skin ulcer (HP:0200042) | 1.99368869 |
| 99 | Osteomyelitis (HP:0002754) | 1.99101091 |
| 100 | Increased IgE level (HP:0003212) | 1.97466986 |
| 101 | Abnormality of the pleura (HP:0002103) | 1.97389489 |
| 102 | Joint swelling (HP:0001386) | 1.94899549 |
| 103 | Keratitis (HP:0000491) | 1.93940110 |
| 104 | Acute hepatic failure (HP:0006554) | 1.93539009 |
| 105 | Urticaria (HP:0001025) | 1.93172269 |
| 106 | Granulocytopenia (HP:0001913) | 1.91653274 |
| 107 | Petechiae (HP:0000967) | 1.91529591 |
| 108 | Abnormal platelet volume (HP:0011876) | 1.91034422 |
| 109 | Viral hepatitis (HP:0006562) | 1.90061256 |
| 110 | Ventricular tachycardia (HP:0004756) | 1.89952968 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 1.88514506 |
| 112 | Impaired platelet aggregation (HP:0003540) | 1.88232940 |
| 113 | Abnormal platelet function (HP:0011869) | 1.88232940 |
| 114 | Glomerulopathy (HP:0100820) | 1.87969880 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 1.86413952 |
| 116 | Keratoconjunctivitis (HP:0001096) | 1.85043377 |
| 117 | Bicuspid aortic valve (HP:0001647) | 1.82485836 |
| 118 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81575080 |
| 119 | Acute myeloid leukemia (HP:0004808) | 1.78345458 |
| 120 | Skin rash (HP:0000988) | 1.78246027 |
| 121 | Recurrent otitis media (HP:0000403) | 1.77567046 |
| 122 | Basal cell carcinoma (HP:0002671) | 1.75841651 |
| 123 | Abnormality of the prostate (HP:0008775) | 1.75746499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.27431019 |
| 2 | KDR | 3.98392322 |
| 3 | TIE1 | 3.21116215 |
| 4 | TXK | 3.02714156 |
| 5 | ITK | 2.75975578 |
| 6 | ZAP70 | 2.68383214 |
| 7 | STK10 | 2.45280746 |
| 8 | TEC | 2.35982432 |
| 9 | TGFBR2 | 2.31275066 |
| 10 | JAK3 | 2.31076998 |
| 11 | BTK | 2.24399600 |
| 12 | BLK | 2.21764498 |
| 13 | EEF2K | 2.13345626 |
| 14 | PRPF4B | 2.07462445 |
| 15 | IRAK4 | 2.04039532 |
| 16 | ERN1 | 1.85892073 |
| 17 | KIT | 1.83118991 |
| 18 | CSK | 1.79827654 |
| 19 | TYK2 | 1.79124471 |
| 20 | FGFR4 | 1.70431795 |
| 21 | MAP3K12 | 1.67312612 |
| 22 | SIK3 | 1.66104986 |
| 23 | GRK6 | 1.64478691 |
| 24 | IKBKE | 1.63718643 |
| 25 | FES | 1.63396839 |
| 26 | MAP2K3 | 1.58596705 |
| 27 | SYK | 1.57877262 |
| 28 | TBK1 | 1.53907467 |
| 29 | CLK1 | 1.49327712 |
| 30 | MAP3K10 | 1.41764123 |
| 31 | PKN2 | 1.41547897 |
| 32 | JAK1 | 1.39240372 |
| 33 | HCK | 1.37489928 |
| 34 | LCK | 1.35312543 |
| 35 | MARK3 | 1.32756003 |
| 36 | SIK2 | 1.28015376 |
| 37 | TGFBR1 | 1.24976878 |
| 38 | TAOK3 | 1.23001114 |
| 39 | EPHB1 | 1.21835037 |
| 40 | CSF1R | 1.20375092 |
| 41 | FGFR3 | 1.15644145 |
| 42 | MAP3K3 | 1.13850949 |
| 43 | NLK | 1.09972566 |
| 44 | NEK2 | 1.06534691 |
| 45 | LRRK2 | 1.03169129 |
| 46 | TRIB3 | 1.02861892 |
| 47 | PTK2B | 1.02832398 |
| 48 | MAP3K1 | 0.98449543 |
| 49 | CDK19 | 0.98275457 |
| 50 | STK24 | 0.96836749 |
| 51 | PRKCH | 0.92686781 |
| 52 | MAP2K6 | 0.89239441 |
| 53 | MAP3K14 | 0.86803050 |
| 54 | LYN | 0.85818885 |
| 55 | TAOK1 | 0.83083701 |
| 56 | MAPK7 | 0.80206707 |
| 57 | YES1 | 0.80110645 |
| 58 | DYRK1B | 0.79785737 |
| 59 | TTN | 0.79519797 |
| 60 | CDK9 | 0.77819649 |
| 61 | BMPR2 | 0.75303745 |
| 62 | PRKD2 | 0.72404328 |
| 63 | EPHA3 | 0.72305863 |
| 64 | RPS6KA4 | 0.69721706 |
| 65 | KSR2 | 0.69563238 |
| 66 | MATK | 0.69369896 |
| 67 | MAP3K6 | 0.69252259 |
| 68 | MAPK12 | 0.67690633 |
| 69 | FLT3 | 0.67657972 |
| 70 | CAMKK1 | 0.66958414 |
| 71 | PIM1 | 0.64476262 |
| 72 | DMPK | 0.64092442 |
| 73 | PRKCQ | 0.62467703 |
| 74 | MAP2K4 | 0.62387467 |
| 75 | JAK2 | 0.59977432 |
| 76 | MAPK4 | 0.59801208 |
| 77 | PDPK1 | 0.56452276 |
| 78 | PIK3CG | 0.53271978 |
| 79 | CDK12 | 0.52853316 |
| 80 | MYLK | 0.51928953 |
| 81 | CDC42BPA | 0.50871523 |
| 82 | MAP3K7 | 0.50719173 |
| 83 | MAP3K13 | 0.50613047 |
| 84 | GRK1 | 0.49952580 |
| 85 | PAK4 | 0.49919949 |
| 86 | PTK6 | 0.49895953 |
| 87 | PRKG2 | 0.49128069 |
| 88 | MAP3K11 | 0.47653453 |
| 89 | MARK2 | 0.47413405 |
| 90 | STK4 | 0.46680245 |
| 91 | RIPK4 | 0.46511351 |
| 92 | TNK2 | 0.45982708 |
| 93 | MAPKAPK3 | 0.44683821 |
| 94 | IKBKB | 0.43878392 |
| 95 | DAPK2 | 0.43736048 |
| 96 | RPS6KA2 | 0.43663556 |
| 97 | CDK8 | 0.41663734 |
| 98 | RPS6KA6 | 0.41303680 |
| 99 | IRAK1 | 0.41219960 |
| 100 | CAMKK2 | 0.41133559 |
| 101 | CDK4 | 0.40903933 |
| 102 | MAPK11 | 0.40856318 |
| 103 | TAOK2 | 0.40398147 |
| 104 | CHUK | 0.40204841 |
| 105 | RET | 0.40030853 |
| 106 | NME2 | 0.39008502 |
| 107 | STK38 | 0.38346606 |
| 108 | PDK1 | 0.38169677 |
| 109 | CSNK1G3 | 0.37136450 |
| 110 | FGR | 0.36983900 |
| 111 | RAF1 | 0.36723706 |
| 112 | PRKCZ | 0.36565212 |
| 113 | BUB1 | 0.35955317 |
| 114 | MAPKAPK2 | 0.35704001 |
| 115 | SGK3 | 0.35173767 |
| 116 | SIK1 | 0.35172843 |
| 117 | ILK | 0.35042794 |
| 118 | SGK2 | 0.34119776 |
| 119 | SMG1 | 0.33870679 |
| 120 | MAP3K5 | 0.33260625 |
| 121 | FYN | 0.32378670 |
| 122 | CSNK1A1L | 0.31783423 |
| 123 | HIPK2 | 0.31668025 |
| 124 | IRAK2 | 0.31228558 |
| 125 | PRKD1 | 0.31014447 |
| 126 | CAMK4 | 0.31005741 |
| 127 | STK11 | 0.30293069 |
| 128 | MELK | 0.28546917 |
| 129 | TESK2 | 0.26447091 |
| 130 | CSNK1G1 | 0.26157226 |
| 131 | MAPK13 | 0.25731615 |
| 132 | RPS6KC1 | 0.23747125 |
| 133 | RPS6KL1 | 0.23747125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.06302202 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.77694622 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.62296622 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.49404320 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35460357 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.16828944 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13118602 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.11564857 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.10769673 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07312595 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.06788492 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.00190251 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99321914 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.98269648 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97110194 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.95168281 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.69464080 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.68582731 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65888744 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.59763851 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58374895 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.48167557 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45434519 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41668870 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41565256 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40111831 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36936806 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35313673 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.33014886 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.31968924 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30931372 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.28351926 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28066436 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27708470 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22260679 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20759406 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.16242217 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.14316107 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13856766 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13485086 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.11748068 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11488815 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.09011653 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07869690 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07627139 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06394569 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03505888 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.02439959 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01958738 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01498423 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98148035 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 0.97674683 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 0.94837955 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92461509 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92281002 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90075352 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.89435418 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89259779 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.88667589 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.84121166 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.83174444 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82887689 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82134919 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78061462 |
| 65 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77192165 |
| 66 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76691962 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76405076 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73942772 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.73904876 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73268114 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72924935 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70489938 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.69262651 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.67744735 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66694504 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66638524 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63913682 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63307238 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.63167091 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63049087 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63021456 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60601245 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60439485 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60327193 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60259076 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58495518 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58311170 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58137101 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57878447 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57211621 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56513216 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56293604 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55836257 |
| 94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53696812 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51903780 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49403855 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48932458 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48592081 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48196781 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.46548266 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46235711 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.44854213 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43866413 |
| 104 | DNA replication_Homo sapiens_hsa03030 | 0.43791174 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42974535 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42569321 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.42248870 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41969712 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40888143 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.40445329 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40414943 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40351308 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40277470 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39950278 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39465671 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38117558 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36655977 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.36153861 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35350848 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32793979 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32791800 |

